CUAMC
MBIO icon

China Universal Asset Management Company’s Mustang Bio MBIO Stock Holding History

China Universal Asset Management Company’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 430
2022
Q3 		$0 Buy
+1
New +$463 ﹤0.01% 450

Other funds holding MBIO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

China Universal Asset Management Company's MBIO Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Mustang Bio (MBIO) in Q4 2022, closing a stake of 1 share.

China Universal Asset Management Company first reported a position in MBIO in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 60 funds tracked by Wall St. Rank hold MBIO as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Mustang Bio position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 1 Mustang Bio share in Q4 2022.
  • China Universal Asset Management Company first reported a position in Mustang Bio in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Mustang Bio position peaked at $0 in Q3 2022.
  • 60 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.